Literature DB >> 15558217

Upregulation of rat P23 (a member of the YjgF protein family) by fasting, glucose diet and fatty acid feeding.

F Levy-Favatier1, A Leroux, B Antoine, B Nedelec, M Delpech.   

Abstract

In a previous study, we identified and purified a 99-amino-acid rat liver-kidney perchloric-acid-soluble 23-kDa protein (P23) which displays 30% identity with a highly conserved domain of heat shock proteins (HSPs), as well as an AT-rich 3' untranslated region, which has also been described to play a role in H70 mRNA life span and protein expression. An identical perchloric-acid-soluble protein inhibiting protein synthesis in a rabbit reticulocyte lysate system was also found 2 years later by another group. More recently, the novel, the YjgF, protein family has been described, comprising, 24 full-length homologues, including P23, highly conserved through evolution, and consisting of approximately 130 residues each and sharing a common ternary structure. Independent studies from different laboratories have provided various hypothetical functions for each of these proteins. The high degree of evolutionary conservation may suggest that these proteins play an important role in cellular regulation. Although the function of none of these proteins is known precisely, we present experimental evidence which, combined with the relationship to glucose-regulating protein revealed here, and the relationship to fatty-acid-binding protein revealed by others, allow us to propose a role for P23. In rat liver, P23 expression is developmentally regulated and modulated by dietary glucose, and its mRNA is induced by starvation, in the presence of fatty-acids and in 3-MeDAB-induced hepatomas. The mRNA encoding mouse liver P23 is also hormonally modulated in a mouse line AT1F8. These data indicate that P23 protein might be a key controller of intermediary metabolism during fasting.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15558217     DOI: 10.1007/s00018-004-4231-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  59 in total

1.  Single-centre survey of the application of cardiovascular magnetic resonance in clinical routine.

Authors:  Florian von Knobelsdorff-Brenkenhoff; Angelika Bublak; Sana El-Mahmoud; Ralf Wassmuth; Christian Opitz; Jeanette Schulz-Menger
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-06-26       Impact factor: 6.875

Review 2.  Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography.

Authors:  Roxy Senior; Harald Becher; Mark Monaghan; Luciano Agati; Jose Zamorano; Jean Louis Vanoverschelde; Petros Nihoyannopoulos
Journal:  Eur J Echocardiogr       Date:  2009-03

3.  Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.

Authors:  Jose Angel Urbano-Moral; Ethan J Rowin; Martin S Maron; Andrew Crean; Natesa G Pandian
Journal:  Circ Cardiovasc Imaging       Date:  2013-11-25       Impact factor: 7.792

4.  Two-dimensional strain analysis of the global and regional myocardial function for the differentiation of pathologic and physiologic left ventricular hypertrophy: a study in athletes and in patients with hypertrophic cardiomyopathy.

Authors:  T Butz; F van Buuren; K P Mellwig; C Langer; G Plehn; A Meissner; H J Trappe; D Horstkotte; L Faber
Journal:  Int J Cardiovasc Imaging       Date:  2010-07-10       Impact factor: 2.357

5.  Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.

Authors:  Dermot Phelan; Patrick Collier; Paaladinesh Thavendiranathan; Zoran B Popović; Mazen Hanna; Juan Carlos Plana; Thomas H Marwick; James D Thomas
Journal:  Heart       Date:  2012-08-03       Impact factor: 5.994

6.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

7.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

8.  Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.

Authors:  Christian Prinz; Maria Schwarz; Ivan Ilic; Kai Thorsten Laser; Roman Lehmann; Eva-Maria Prinz; Thomas Bitter; Jürgen Vogt; Frank van Buuren; Nikola Bogunovic; Dieter Horstkotte; Lothar Faber
Journal:  Can J Cardiol       Date:  2012-06-30       Impact factor: 5.223

9.  The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy.

Authors:  Ankur Gulati; Tevfik F Ismail; Andrew Jabbour; Francisco Alpendurada; Kaushik Guha; Nizar A Ismail; Sadaf Raza; Jahanzaib Khwaja; Tristan D H Brown; Kishen Morarji; Emmanouil Liodakis; Michael Roughton; Ricardo Wage; Tapesh C Pakrashi; Rakesh Sharma; John-Paul Carpenter; Stuart A Cook; Martin R Cowie; Ravi G Assomull; Dudley J Pennell; Sanjay K Prasad
Journal:  Circulation       Date:  2013-08-21       Impact factor: 29.690

10.  Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy.

Authors:  Ankur Gulati; Tevfik F Ismail; Andrew Jabbour; Nizar A Ismail; Kishen Morarji; Aamir Ali; Sadaf Raza; Jahanzaib Khwaja; Tristan D H Brown; Emmanouil Liodakis; Arun J Baksi; Rameen Shakur; Kaushik Guha; Michael Roughton; Ricardo Wage; Stuart A Cook; Francisco Alpendurada; Ravi G Assomull; Raad H Mohiaddin; Martin R Cowie; Dudley J Pennell; Sanjay K Prasad
Journal:  Eur J Heart Fail       Date:  2013-03-08       Impact factor: 15.534

View more
  3 in total

Review 1.  RidA Proteins Protect against Metabolic Damage by Reactive Intermediates.

Authors:  Jessica L Irons; Kelsey Hodge-Hanson; Diana M Downs
Journal:  Microbiol Mol Biol Rev       Date:  2020-07-15       Impact factor: 11.056

2.  CHRD, a plant member of the evolutionarily conserved YjgF family, influences photosynthesis and chromoplastogenesis.

Authors:  Yael Leitner-Dagan; Marianna Ovadis; Amir Zuker; Elena Shklarman; Itzhak Ohad; Tzvi Tzfira; Alexander Vainstein
Journal:  Planta       Date:  2006-07-15       Impact factor: 4.116

3.  Genomic and experimental evidence for multiple metabolic functions in the RidA/YjgF/YER057c/UK114 (Rid) protein family.

Authors:  Thomas D Niehaus; Svetlana Gerdes; Kelsey Hodge-Hanson; Aleksey Zhukov; Arthur J L Cooper; Mona ElBadawi-Sidhu; Oliver Fiehn; Diana M Downs; Andrew D Hanson
Journal:  BMC Genomics       Date:  2015-05-15       Impact factor: 3.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.